ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 44 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,000 | -40.0% | 12,563 | -3.4% | 0.00% | – |
| Q2 2022 | $15,000 | -42.3% | 13,005 | +3.2% | 0.00% | – |
| Q1 2022 | $26,000 | -27.8% | 12,605 | +2.1% | 0.00% | – |
| Q4 2021 | $36,000 | -59.6% | 12,350 | -41.4% | 0.00% | – |
| Q3 2021 | $89,000 | -25.2% | 21,059 | -6.7% | 0.00% | – |
| Q2 2021 | $119,000 | +9.2% | 22,578 | -3.8% | 0.00% | – |
| Q1 2021 | $109,000 | +153.5% | 23,477 | +79.1% | 0.00% | – |
| Q4 2020 | $43,000 | +13.2% | 13,106 | +15.2% | 0.00% | – |
| Q3 2020 | $38,000 | +2.7% | 11,378 | +4.7% | 0.00% | – |
| Q2 2020 | $37,000 | -9.8% | 10,863 | +2.3% | 0.00% | – |
| Q1 2020 | $41,000 | -88.3% | 10,622 | -77.1% | 0.00% | -100.0% |
| Q3 2019 | $351,000 | -31.8% | 46,480 | +22.3% | 0.00% | 0.0% |
| Q2 2019 | $515,000 | – | 38,020 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 3,662,342 | $7,874,000 | 0.16% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 213,469 | $438,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 150,914 | $309,000 | 0.04% |
| Bernardo Wealth Planning LLC | 30,469 | $62,000 | 0.03% |
| Penserra Capital Management LLC | 351,154 | $719,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,900 | $361,000 | 0.01% |
| Founders Capital Management | 3,000 | $9,000 | 0.01% |
| King Wealth Management Group | 16,000 | $33,000 | 0.01% |
| Aquatic Capital Management LLC | 1,900 | $4,000 | 0.01% |
| Newbridge Financial Services Group, Inc. | 6,075 | $12,000 | 0.01% |